Genetic Tech Spn ADR (GENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2024 | 06-2023 | 06-2022 | 06-2021 | 06-2020 | |
| Sales | 5,027 | 5,848 | 4,930 | 90 | 7 |
| Cost of Goods | 2,466 | 2,919 | 2,186 | 270 | 169 |
| Gross Profit | 2,561 | 2,929 | 2,743 | -180 | -162 |
| Operating Expenses | 10,908 | 11,865 | 8,127 | 5,377 | 5,000 |
| Operating Income | -7,881 | -8,017 | -5,197 | -5,287 | -4,993 |
| Interest Expense | 78 | 148 | 26 | 0 | 0 |
| Other Income | 78 | 148 | 26 | -2 | 898 |
| Pre-tax Income | -7,881 | -8,017 | -5,197 | -5,288 | -4,095 |
| Income Tax | N/A | -107 | -23 | N/A | N/A |
| Net Income Continuous | -7,881 | -7,911 | -5,174 | -5,288 | -4,095 |
| Net Income | $-7,881 | $-7,911 | $-5,174 | $-5,288 | $-4,095 |
| EPS Basic Total Ops | -1.79 | -2.34 | -1.69 | -1.79 | -3.00 |
| EPS Basic Continuous Ops | -1.79 | -2.34 | -1.68 | -1.86 | -2.96 |
| EPS Diluted Total Ops | -1.79 | -2.34 | -1.69 | -1.79 | -3.00 |
| EPS Diluted Continuous Ops | -1.79 | -2.34 | -1.68 | -1.86 | -2.96 |
| EPS Diluted Before Non-Recurring Items | -1.79 | -2.35 | -1.70 | -1.80 | -2.95 |
| EBITDA(a) | $-7,803 | $-7,869 | $-5,171 | $-5,287 | $-4,993 |